This is my another story on victimization of investors in biotech stocks, who don't understand a basic accounting and buy biotech stocks because of wishful thinking and dreams. Let's go back to earth and...
After it's IPO in 2009, GAME fell as did the market. As we see a rebound in our own market GAME will follow suit. GAME is trading at about 50% of its original IPO issuance price. Do your own value analysis...
